Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used in PET or SPECT imaging. This includes advances in myocardiac perfusion agents.

Siemens PETNET Solutions, 18F NaF, ANDA approval, PET radiopharmaceutical

Image courtesy of Siemens Healthcare

News | Radiopharmaceuticals and Tracers | October 02, 2015
October 2, 2015 — Siemens’ PETNET Solutions has received Abbreviated New Drug Application (ANDA) approval from the U.S...
blood clot detection, single scan, rats, radionuclides, Peter Caravan, whole body

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image courtesy of Peter Caravan, Ph.D.

News | PET Imaging | September 23, 2015
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to...
molecular imaging, imaging agent, GA-68 PSMA, improved detection, early recurrent, prostate cancer
News | Radiopharmaceuticals and Tracers | September 18, 2015
September 18, 2015 — A recently developed drug was significantly better at detecting recurring prostate cancer in early...
Novation, Mo-99, NNSA 2015 meeting, reliable supplies, domestic production
News | Radiopharmaceuticals and Tracers | September 17, 2015
September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation...
PET, imaging agent, hidden blood clots, MGH, radiopharmaceutical probe, 64Cu-FBP8
News | Radiopharmaceuticals and Tracers | September 16, 2015
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the...
ImaginAb, prostate imaging agent, prostate cancer, World Molecular Imaging Conference, molecular imaging, PET
News | Prostate Cancer | September 14, 2015
September 14, 2015 — ImaginAb Inc. has released interim results from a Phase 2 clinical trial of IAB2M, the company's...
Zevacor, IBA, 70 MeV cyclotron, Cyclone 70P, radiopharmaceuticals
News | Radiopharmaceuticals and Tracers | September 11, 2015
September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET)...
News | Radiopharmaceuticals and Tracers | September 11, 2015
September 11, 2015 — Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of...
Navidea, SBIR grant, NCI, NIH, Kaposi's sarcoma, Tc99m tilmanocept, SPECT

Image courtesy of Navidea Biopharmaceuticals Inc.

News | Radiopharmaceuticals and Tracers | September 03, 2015
September 3, 2015 — Navidea Biopharmaceuticals Inc. received initial notice of award for a Fast Track Small Business...
NorthStar Medical Radioisotopes, approval, routine production, Molybdenum-99, Mo-99, University of Missouri Research Reactor, MURR
News | Radiopharmaceuticals and Tracers | August 31, 2015
August 31, 2015 — NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-...
18F-DCFBC PET/CT
News | Prostate Cancer | August 21, 2015
August 21, 2015 — A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish...
The ITM Group, in-licensing, DOTA-Zoledronate, theranostic agent, bone metastases, PET imaging
News | Radiopharmaceuticals and Tracers | August 20, 2015
August 20, 2015 — The ITM Group announced that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a...
Lymphoseek, Navidea, injection site pain, study, breast cancer patients, tracer
News | Radiopharmaceuticals and Tracers | August 20, 2015
August 20, 2015 — Navidea Biopharmaceuticals announced publication of the results from an investigator-initiated,...
IBA Molecular North America, IBAM NA, acquisition, Illinois Health and Science, IBA S.A.
News | Radiopharmaceuticals and Tracers | August 10, 2015
August 10, 2015 — IBA (Ion Beam Applications S.A.) announced the completion of the divestiture of IBA Molecular North...
Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers | July 30, 2015
July 30, 2015 — Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of...
Blue Earth Diagnostics, fluciclovine, 18F, orphan drug designation, PET
News | Molecular Imaging | July 09, 2015
July 9, 2015 - Blue Earth Diagnostics Ltd (BED) announced it has received both U.S. Food and Drug Administration (FDA)...
Medraysintell, nuclear medicine, World Market Report, radiopharmaceuticals
News | Molecular Imaging | July 06, 2015
July 6, 2015 - Medraysintell released its updated World Market Report and Directory on Nuclear Medicine, Edition 2015,...
Navidea, Manocept, CD206 receptor, rheumatoid arthritis
News | Molecular Imaging | June 26, 2015
June 26, 2015 - Navidea Biopharmaceuticals announced that results from several pre-clinical Manocept studies in...
Siemens, PETNET Solutions, prostate cancer, PET/CT imaging, tracer, New York
News | Molecular Imaging | June 24, 2015
June 24, 2015 - Siemens' PETNET Solutions, a wholly owned subsidiary of Siemens Healthcare, announced it will provide...
Siemens, Blue Earth Diagnostics, PET/CT, U.S. agreement, PETNET
News | June 12, 2015
June 12, 2015 - Siemens' PETNET Solutions Inc. has entered into a nationwide agreement with U.K.-based Blue Earth...